Skip to ContentSkip to Navigation
University of Groningenfounded in 1614  -  top 100 university
About us Practical matters How to find us dr. H.J. (Dika) Luijendijk

Research interests

My research focuses on advancing psychogeriatric care for older persons at home and in nursing homes. After working as a psychogeriatrician for over a decade, I joined the Department of Primary and Long-Term Care at UMCG in 2014. My current projects include studies on delirium in dementia (detection, prevalence, screening instruments), the effect of soundscapes and relocation, and appropriate prescribing. I also have a strong interest in critical appraisal of drug trials including quantitative methods to assess risk of bias. Throughout my career, I have contributed to evidence-based medicine through teaching, medical textbooks, and national guidelines. 

Publications

A matched case-control study on polypharmacy and co-medications one year before drug treatment for Alzheimer's disease

Comment on Chwal et al. On-Target Low-Density Lipoprotein Cholesterol in Adults with Diabetes Not at High Cardiovascular Disease Risk Predicts Greater Mortality, Independent of Early Deaths or Frailty. J. Clin. Med. 2024, 13, 7667

Delirium in home-dwelling older people during regular GP consultation; text-analysis of routinely collected health care data

Involving experts by experience in quality of life research: insights form the SPREAD+ consortium

Probleemgedrag Bij Mensen Met Dementie

The Impact of Relocations Within Nursing Home Care on Long-Term Care Residents According to Stakeholders: A Qualitative Study

An exploration of relocation initiatives deployed within and between nursing homes: a qualitative study

Delier bij volwassenen en ouderen

Delirium among older people living at home: a systematic review

Depressive Signs and Daily Life of Residents When Relocating from a Regular to an Innovative Nursing Home

Press/media

Dit is waarom de absolute cijfers achter een medicijn voor jou belangrijk zijn

Artsen in opstand: Nieuwe cholesterolwaarden gezond voor patiënt of industrie? – deel 2

Artsen schrijven dure cholesterolverlagers vaker voor dan toegestaan: kost zorgverzekeraars miljoenen

Schnakkelende artsen onderhouden warme banden met Big Pharma

Verklein de kans op dementie